From April 16 to 19, 2024, Haimen Pharma Inc., (hereafter Haimen Pharma), Sinotherapeutics Inc Production Base, has received an on-site inspection by the Pharmaceutical and Medical Devices Agency (PMDA) of Japan. The inspection covered the following systems: quality, production, facilities and equipment, laboratory control, materials and packaging labels etc system.
Recently, Haimen Pharma received a “Notice of GMP Compliance Inspection Results” issued by Japan PMDA, confirming that it has passed the Japan PMDA certification. This certification is not only a recognition of the effective operation of production and quality management system, but also a result of strict implementation of international advanced GMP standards throughout the whole process.
About SinoT：
SinoT is a specialty pharma with focus on the research & development, commercialization and sale of complex generics and 505(b2) products. We dedicated to developing high quality medicines that meet with international standards. We’ll do more than our best to benefit the patients in the future.
Shanghai Head Office
99 Haike Road, Bldg. 3, 1st Flr., Pudong District Shanghai 201210, P.R. China
Manufacturing Site in Jiangsu
No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province
